Trials / Unknown
UnknownNCT01974518
Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
A PILOT STUDY TO ASSESS THE EFFICACY OF RITUXIMAB VERSUS COMBINATION OF RITUXIMAB AND INTRAVENOUS CYCLOPHOSPHAMIDE IN THE TREATMENT OF REFRACTORY PEMPHIGUS
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Uprety Shraddha · Unknown
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effectiveness of rituximab alone vs combination of rituximab and cyclophosphamide in the treatment of pemphigus not responding adequately to routine medications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rituximab and Cyclophosphamide IV |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2013-11-01
- Last updated
- 2014-10-30
Locations
2 sites across 1 country: India
Source: ClinicalTrials.gov record NCT01974518. Inclusion in this directory is not an endorsement.